Loading company…
Nautilus develops and commercializes pharmaceutical products for neurology and pain management.
Nautilus Neurosciences develops and commercializes pharmaceutical products focused on neurology and pain management. It is based in Bedminster, US. In 2013, it sold the U.S. and Canadian rights to CAMBIA® to Depomed, Inc. for USD 53.7 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in